A Novel Homozygous Variant of SETX Causes Ataxia with Oculomotor Apraxia Type 2

다국어 초록 (Multilingual Abstract)

Background and Purpose Autosomal recessive cerebellar ataxias constitute a highly heterogeneous group of neurodegenerative disorders. This study was carried out to determine the clinical and genetic causes of ataxia in two families from Pakistan.
Methods Detailed clinical investigations were carried out on probands in two consanguineous families. Magnetic resonance imaging was performed. Exome sequencing data were examined for likely pathogenic variants. Candidate variants were checked for cosegregation with the phenotype using Sanger sequencing. Public databases including ExAC, GnomAD, dbSNP, and the 1,000 Genome Project as well as ethnically matched controls were checked to determine the frequencies of the alleles. Conservation of missense variants was ensured by aligning orthologous protein sequences from diverse vertebrate species.
Results Reverse phenotyping identified spinocerebellar ataxia, autosomal recessive 1 [OMIM 606002, also referred to as ataxia oculomotor apraxia type 2 (AOA2)] and ataxia telangiectasia (OMIM 208900) in the two families. A novel homozygous missense mutation c.202 C>T (p.
Arg68Cys) was identified within senataxin, SETX in the DNA of both patients in one of the families with AOA2. The patients in the second family were homozygous for a known variant in ataxia-telangiectasia mutated (ATM) gene: c.7327 C>T (p.Arg2443Ter). Both variants were absent from 100 ethnically matched control chromosomes and were either absent or present at very low frequencies in the public databases.
Conclusions This report extends the allelic heterogeneity of SETX mutations causing AOA2 and also presents an asymptomatic patient with a pathogenic ATM variant.

참고문헌 (Reference)

1 Groh M, "Senataxin: genome guardian at the interface of transcription and neurodegeneration" 429 : 3181-3195, 2017

2 Lavin MF, "Senataxin protects the genome: implications for neurodegeneration and other abnormalities" 1 : e25230-, 2013

3 Becherel OJ, "Senataxin plays an essential role with DNA damage response proteins in meiotic recombination and gene silencing" 9 : e1003435-, 2013

4 Yeo AJ, "Senataxin controls meiotic silencing through ATR activation and chromatin remodeling" 1 : 15025-, 2015

5 Hammer MB, "SLC25A46 mutations associated with autosomal recessive cerebellar ataxia in North African families" 17 : 208-212, 2017

6 Rudnik-Schoneborn S, "SETX gene mutation in a family diagnosed autosomal dominant proximal spinal muscular atrophy" 22 : 258-262, 2012

7 Nishida K, "RNA binding proteins and genome integrity" 18 : E1341-, 2017

8 Davis MY, "Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival" 335 : 134-138, 2013

9 Roohi J, "New diagnosis of atypical ataxia-telangiectasia in a 17-year-old boy with T-cell acute lymphoblastic leukemia and a novel ATM mutation" 62 : 581-584, 2017

10 Duquette A, "Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy" 57 : 408-414, 2005

11 Fogel BL, "Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2" 23 : 4758-4769, 2014

12 Ciesla N, "Manual muscle testing: a method of measuring extremity muscle strength applied to critically ill patients" 50 : 2632-, 2011

13 Bassuk AG, "In cis autosomal dominant mutation of senataxin associated with tremor/ataxia syndrome" 8 : 45-49, 2007

14 Kenna KP, "Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing" 50 : 776-783, 2013

15 Chen YZ, "DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)" 74 : 1128-1135, 2004

16 Mariani LL, "Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein" 7 : 15284-, 2017

17 Rudnik-Schoneborn S, "Clinical utility gene card for: proximal spinal muscular atrophy (SMA)-update 2015" 2015

18 Sandoval N, "Characterization of ATM gene mutations in 66 ataxia telangiectasia families" 8 : 69-79, 1999

19 Telatar M, "Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations" 62 : 86-97, 1998

20 Brunberg JA, "Ataxia" 29 : 1420-1422, 2008

21 Choudhury SD, "Altered translational repression of an RNA-binding protein, Elav by AOA2-causative senataxin mutation" 2017

22 Berger ND, "ATM-dependent pathways of chromatin remodelling and oxidative DNA damage responses" 372 : 20160283-, 2017

23 Bernstein JL, "ATM, radiation, and the risk of second primary breast cancer" 93 : 1121-1127, 2017

24 Sasaki T, "ATM mutations in patients with ataxia telangiectasia screened by a hierarchical strategy" 12 : 186-195, 1998

25 Mansfield SA, "ATM mutations for surgeons" 16 : 407-410, 2017

26 Breedveld GJ, "A new locus for a childhood onset, slowly progressive autosomal recessive spinocerebellar ataxia maps to chromosome 11p15" 41 : 858-866, 2004

27 Wright J, "A high frequency of distinct ATM gene mutations in ataxia-telangiectasia" 59 : 839-846, 1996

28 Richard P, "A SUMO-dependent interaction between senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage" 27 : 2227-2232, 2013